Last Updated: May 3, 2026

mannitol; sorbitol - Profile


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for mannitol; sorbitol and what is the scope of freedom to operate?

Mannitol; sorbitol is the generic ingredient in two branded drugs marketed by Hospira and Otsuka Icu Medcl, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Summary for mannitol; sorbitol
US Patents:0
Tradenames:2
Applicants:2
NDAs:3

US Patents and Regulatory Information for mannitol; sorbitol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira SORBITOL-MANNITOL mannitol; sorbitol SOLUTION;IRRIGATION 080224-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira SORBITOL-MANNITOL IN PLASTIC CONTAINER mannitol; sorbitol SOLUTION;IRRIGATION 017636-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Otsuka Icu Medcl SORBITOL-MANNITOL IN PLASTIC CONTAINER mannitol; sorbitol SOLUTION;IRRIGATION 018316-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Mannitol; sorbitol Market Analysis and Financial Projection

Last updated: February 13, 2026

What is the current market landscape for mannitol and sorbitol?

Mannitol and sorbitol are polyols used primarily as excipients, sweeteners, and osmotic diuretics. The global market for these compounds is driven by their applications in pharmaceuticals, food, and industrial sectors.

Market size and growth

  • The global mannitol market was valued at approximately $400 million in 2022, projected to grow at a compound annual growth rate (CAGR) of around 4.5% from 2023 to 2030.
  • The sorbitol market was valued at approximately $2.1 billion in 2022, with an expected CAGR of 3.7% over the same period.

Key drivers

  • Increasing demand for low-calorie sweeteners in food and beverages.
  • Expanding pharmaceutical applications, notably in osmotic diuretics and tablet excipients.
  • Rising awareness and regulatory acceptance of polyols in medical and food products.

Key regional markets

  • Asia-Pacific dominates due to large production bases and food industry expansion.
  • North America maintains significant pharmaceutical demand.
  • Europe exhibits stable growth with emphasis on food and pharmaceutical compliance regulation.

How do the fundamental attributes and patent landscapes shape investment?

Patent expiration and R&D pipeline

  • As of 2023, key patents covering mannitol and sorbitol manufacturing processes have begun expiring between 2023 and 2025.
  • Several generic production processes are accessible, increasing market competition.
  • Ongoing research aims to develop more efficient synthesis methods, enhancing purity and reducing costs.

Competitive landscape

  • Major players include Roquette, Cargill, and SPI Pharma, holding significant manufacturing capacity.
  • Patent expirations open opportunities for new entrants with proprietary extraction or synthesis technologies.
  • Companies investing in novel applications, such as targeted drug delivery or enhanced solubility formulations, can diversify revenue streams.

Regulatory considerations

  • Both compounds are generally recognized as safe (GRAS) within food and pharmaceutical regulatory frameworks.
  • Stringent quality standards enforce Good Manufacturing Practice (GMP) compliance.
  • Future regulatory developments could influence the market, particularly concerning purity specifications for pharmaceutical-grade products.

What are the critical investment risks and opportunities?

Risks

  • Market saturation due to mature markets and generic manufacturing.
  • Fluctuations in raw material supply, notably glucose and other carbohydrate sources.
  • Regulatory shifts or safety concerns, especially regarding oral tolerance and gastrointestinal effects.

Opportunities

  • Development of high-purity or specialty derivatives with improved pharmacological profiles.
  • Growing demand in emerging markets for pharmaceuticals and functional foods.
  • Potential integration with advanced drug delivery systems, increasing application scope.

How do financial fundamentals compare with industry standards?

Metric Mannitol Sorbitol
Market valuation (2022) ~$400 million ~$2.1 billion
CAGR (2023–2030) 4.5% 3.7%
Primary application Osmotic diuretics, excipients Sweetener, excipients
Manufacturing cost (estimated) Competitive; primary source is glucose Similar; raw materials influence cost
Patent status Several patents expiring from 2023 Similar; price competition increases

Investment in these compounds hinges on access to manufacturing patents, quality control infrastructure, and R&D pipeline health.

What strategic considerations should investors note?

  • Monitoring patent expirations and generic entry points.
  • Investing in companies with novel formulations or improved extraction techniques.
  • Assessing regional market expansion potential, especially in Asia-Pacific.
  • Ensuring compliance with evolving regulatory standards to mitigate legal risks.

Key Takeaways

  • The mannitol and sorbitol markets are mature, with steady growth driven by pharmaceutical and food applications.
  • Patent expirations create opportunities for entrants with innovative manufacturing processes.
  • Cost dynamics are influenced by raw material prices and process efficiencies.
  • Despite mature markets, advances in application-specific formulations and regional expansion drive potential growth.
  • Regulatory and safety standards remain critical factors for market access and quality assurance.

FAQs

1. When do key patents for mannitol and sorbitol expire?
Major patents start expiring between 2023 and 2025, opening opportunities for generics and process innovation.

2. What are the main cost drivers for manufacturing these polyols?
Raw materials, notably glucose derived from biomass, and process efficiencies influence costs significantly.

3. Which regions present the best opportunities for investment?
Asia-Pacific offers large-scale production and growing demand, while emerging markets in Africa and Latin America show potential for expansion.

4. How do regulatory standards impact market entry?
Strict quality standards and GMP compliance are necessary for pharmaceutical-grade products, which can pose barriers but also ensure market stability.

5. What R&D trends are shaping the future for mannitol and sorbitol?
Research focuses on high-purity derivatives, cost reduction, and novel delivery systems, adding value beyond traditional applications.


Sources:
[1] MarketsandMarkets, "Polyols Market," 2022.
[2] Grand View Research, "Sorbitol Market," 2022.
[3] U.S. FDA, "Regulatory Status of Polyols," 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.